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ENGLISH SUMMARY 
In clinical practice, systemic measurements such as pulse, blood pressure, cardiac 
output, oxygen-derived variables, and blood lactate levels are used to assess tissue 
perfusion and thereby tissue oxygenation. The systemic measurements are global 
assessments and often require invasive techniques that limit an early detection of 
shock. During shock and low blood flow states, complex regulatory mechanisms 
ensure a stable supply and delivery of oxygen to the brain at the expense of other 
organs such as muscle tissue. Also, during cardiopulmonary bypass (CPB) the non-
pulsatile blood flow produced by the CPB is distributed according to an organ 
hierarchy, preserving blood flow to the brain as the top priority at the expense of 
muscle tissue that has the lowest priority. Cerebral and muscle metabolism can be 
assessed by regional measurements that extend from advanced methods leading to 
calculation of tissue perfusion using dynamic positron emission tomography (PET-
CT) and cerebral and muscle tissue metabolomics measured by microdialysis to 
non-invasive and continuous near-infrared spectroscopy (NIRS) that reflects the 
tissue oxygenation balance in superficially located organs, e.g. brain and muscle 
tissue, thereby providing information on tissue oxygenation in the highest and the 
lowest prioritised organs during hypoperfusion.  
The overall aim of this PhD thesis was to investigate the tissue metabolism of the 
brain and muscle using cerebral NIRS (human study) and muscle NIRS 
(experimental studies) and evaluate the measurement with more advanced regional 
monitoring methods, i.e. microdialysis and PET-CT during low blood flows using 
CPB, thereby gaining insight into metabolism and oxygenation balance at the 
extreme ends of the organ hierarchy during hypoperfusion. 
In study I, we hypothesised that cerebral oxygenation saturation (rSO2) and hence 
perfusion measured by NIRS was preserved in 22 cardiac surgery patients during 
CPB. The study was a cross-over study with random allocation to a CPB blood flow 
for 20 min based on either the calculated flow (2.4 L/min/m2) or the individual 
measured CO prior to CPB, and then a switch to the opposite blood flow for another 
20 min. rSO2 was preserved during both CPB blood flows, with the individual 
estimated blood flow ranging from 1.9 to 3.1 L/min/m2 in cardiac surgery patients.  
In study II, we hypothesized that muscle tissue oxygenation saturation (StO2) 
measured with NIRS 1) was a fast reacting indicator of global hypoperfusion during 
CPB and 2) that it follows the changes in systemic acid/base balance and in 
metabolism in remote organs in an experimental porcine model. Twelve pigs were 
coupled to CPB initiated with a blood flow of 60 mL/kg/min for 1 hour, and 
hereafter randomised to a CPB low blood flow of 47.5 or 35 mL/kg/min for 1 hour 
and returned to a CPB blood flow of 60 mL/kg/min for 1 hour. StO2 was compared 
with microdialysis obtained from muscle tissue, intestinal tissue, and brain tissue 
during all CPB blood flows. During inadequate systemic circulation, StO2 reacted 
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rapidly and indicated insufficient global tissue perfusion even when systemic 
circulation was restored.  
In study III, we hypothesized that changes in muscle tissue perfusion measured with 
PET-CT would be reflected by parallel changes in StO2 measured by NIRS. In eight 
pigs, normothermic CPB was established with a blood flow of 60 mL/kg/min for 1 
h. Thereafter pigs were randomised to a blood flow of either 47.5 or 35 mL/kg/min 
for 1 h followed by a blood flow of 60 ml/kg/min for an additional hour. PET-CT 
scans were performed at spontaneous circulation and each blood flow. StO2 was 
compared with values of the dynamic PET-CT scan of the corresponding regional 
muscle at all blood flows. StO2 remained high until muscle blood flow had 
decreased to about 50%, after which StO2 almost linearly followed the fall in muscle 
blood flow.  
In study IV, we hypothesised that CPB blood flow is more important than mean 
arterial blood pressure (MAP) for cerebral perfusion during normothermic CPB. 
This study is part of study III. During the study period, no intervention was 
undertaken with regard to the changing MAP. At the end of each blood flow stage, 
MAP and cerebral blood perfusion (CBF) measured with PET-CT using 15O-labeled 
water were determined. We demonstrated that CPB blood flow is a main 
determinant of CBF and that a high MAP does not protect against cerebral 
hypoperfusion. 
In summary, this thesis indicates that the blood flow during normothermic CPB may 
be safe at a wider range (1.9–3.1 L/min/m2) in uncomplicated cardiac surgery 
patients evaluated by cerebral NIRS, but in an experimental porcine model with 
very low blood flows during CPB, we found CBF to be flow dependent and that an 
increased MAP did not protect against cerebral hypoperfusion. NIRS measurements 
above the lowest prioritised organ, the muscle tissue, demonstrated that StO2 to 
react rapidly due to insufficient global tissue, but StO2 remained high until muscle 
blood flow had decreased to about 50%. In conclusion, muscle NIRS could serve as 
an early warning signal of insufficient muscle metabolism, but further studies are 
needed. 
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DANSK RESUME 
I klinisk praksis anvendes systemiske parametre, såsom puls, blodtryk, 
minutvolumen, afledte oxygen variabler (blandet eller central venøs saturation), 
samt blod laktat til at vurdere sufficient vævsgennemblødning og dermed 
iltforbruget af periferier vævene. De systemiske parametre er globale målemetoder 
og kræver ofte invasive teknikker og derfor er disse målemetoder af begrænset 
værdi, når shock tilstande skal erkendes tidligt i forløbet. I forbindelse med shock 
samt tilstande med nedsat vævsgennemblødning styres fordelingen af systemiske 
blodvolumen til organerne af komplekse reguleringsmekanismer der sikrer 
sufficient blodgennemstrømning og dermed ilttilførsel til hjernen på bekostning af 
andre organer såsom muskelvæv. Ligeså når der anvendes hjertelungemaskine 
fordeles den non-pulsatile blodgennemstrømning produceret af hjertelungemaskinen 
efter et organhierarki, hvor blodgennemstrømning til hjerne prioriteres først, og 
muskelvæv til sidst. Hjernens og musklernes metabolisme kan måles med regionale 
målemetoder, strækkende sig fra omfattende 1) avancerede målinger med dynamisk 
positron emission tomografi (PET-CT), der via komplekse beregninger angiver den 
regionale vævsgennemblødning 2) vævsbiomarkører der måles med mikrodialyse til 
3) non-invasive og kontinuerlig infrarød spektroskopi (NIRS) monitorering, der 
afspejler det organspecifikke iltforbrug i overfladiske beliggende væv, såsom hjerne 
og muskelvæv.  Dermed opnår man indsigt i det organspecifikke iltforbrug i vævene 
i forhold til disses prioritering (prioriteret højeste og lavest) i organ hierarkiet.  
Det overordnede formål med PhD afhandlingen var, at undersøge den 
organspecifikke metabolisme i hjerne og muskler ved brug af cerebral NIRS 
(humant studie) og muskel NIRS (eksperimentalt studie), samt at sammenholde 
NIRS målingerne med mere avancerede regionale monitoringsmetoder såsom 
mikrodialyse og PET-CT ved nedsat vævsgennemblødning ved brug af 
hjertelungemaskinen, og dermed få indsigt i organspecifikke metabolisme og 
iltforbrug i det højeste og laveste prioriterede væv i organ hierarkiet. 
I studie I, var hypotesen, at den cerebrale iltmætning (rSO2) og dermed perfusion 
målt ved NIRS var bevaret i 22 hjertekirurgiske patienter under CPB. I et cross over 
studie blev de hjertekirurgiske patienter randomiseret til én af to grupper. Den ene 
gruppe startede med det beregnede blod flow (2.4 L/min/m2) i 20 minutter efterfulgt 
af yderligere 20 minutter med det individuelt thermodilutionsmålte blod flow målt 
forud for hjertelungemaskinen. Den anden gruppe startede med det individuelt 
thermodilutionsmålte blod flow i 20 minutter efterfulgt af det beregnede blod flow 
(2.4 L/min/m2) i 20 minutter. Hjernens iltmætning målt med NIRS var bevaret under 
begge blod flows med det individuelle blod flow fra 1.9 til 3.1 L/min/m2 i de 
hjertekirurgiske patienter.  
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I studie II var hypotesen, at muskelvævs iltmætning (StO2) målt med NIRS 1) var en 
hurtigt reagerende, indirekte markør for global hypoperfusion under CPB og 2) at 
StO2 reflekterede ændringerne i systemisk syre/base balance og metabolisme i de 
perifere organer undersøgt i en grisemodel. Tolv grise blev tilkoblet 
hjertelungemaskine med et blod flow på 60 mL/kg/min i en time og herefter 
randomiseret til et lavt blod flow 47,5 eller 35 mL/kg/min i en 1 time og til sidst 1 
time på det oprindelige blod flow 60 mL/kg/min. StO2 blev sammenlignet med 
mikrodialyse i muskelvæv, tarmvæg og i hjernevæv under alle CPB blod flows. Ved 
utilstrækkeligt blod flow reagerede StO2 hurtigt og indikerede utilstrækkelig 
systemisk vævsgennemblødning, selv når systemisk cirkulation blev reetableret efter 
perioden med systemisk hypoperfusion. 
I studie III var hypotesen, at ændringer i muskelvævsgennemblødningen målt med 
PET-CT ville blive afspejlet i parallelle ændringer i StO2 målt ved NIRS. Otte grise 
fik etableret normothermisk CPB med blod flow 60 mL/kg/min i 1 time. 
Efterfølgende blev de randomiseret til et blod flow på enten 47,5 eller 35 
mL/kg/min i 1 time, og til sidst efterfulgt af 1 time med blod flow på 60 mL/kg/min. 
PET-CT blev udført under spontan cirkulation og efter hver blod flow periode. StO2 
blev sammenlignet med den PET-CT beregnede muskel blodgennemstrømning. 
StO2 forblev høj indtil muskel blodgennemstrømning var faldet til ca. 50%, 
hvorefter StO2 næsten faldt lineær med muskel blodgennemstrømning.  
I studie IV var hypotesen, at blod flowet leveret af hjertelungemaskinen var 
vigtigere end middel arterieblodtrykket (MAP) for den cerebrale perfusion ved lavt 
blod flow. Analyserne var lavet på data indsamlet under studie III. Under studiet 
blev MAP ikke farmakologisk behandlet. Ved afslutningen af hver blod flow 
periode blev MAP og den cerebrale blod perfusion (CBF) målt med PET-CT, og 
den præcise blodgennemstrømning af hjernen beregnet og sammenlignet med MAP. 
Studiet viste, at et CPB leveret blod flow var en vigtig determinant for hjernes 
blodgennemstrømning og at et højt MAP ikke sikrede mod cerebral hypoperfusion. 
Opsummerende viste studierne, at ilttilbuddet til hjernen var bevaret ved CPB blod 
flow 1.9-3.1 L/min/m2 vurderet med NIRS i ukomplicerede hjertekirurgiske 
patienter, men i den eksperimentelle grisemodel med utilstrækkelig systemisk 
cirkulation var det CPB leverede blod flow vigtigere for opretholdelsen af hjernens 
vævgennemblødning, da et øget MAP ikke sikrede mod nedsat hjerne 
vævgennemblødning. Ved brug af NIRS på det lavest prioriterede organ, - 
muskelvæv viste resultaterne, at StO2 reagerede hurtigt og indikerede utilstrækkelig 
systemisk vævsgennemblødning, når CPB blodflow blev reduceret signifikant. StO2 
forblev høj indtil muskel blodgennemstrømningen var faldet til cirka 50%. I visse 
kliniske tilstande kan StO2 måske være en tidlig markør for utilstrækkelig ilttilbud 
til muskel og dermed metabolisme, men yderligere studier er nødvendige. 
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sets of slices correspond to time points t = 0.3 min, 0.6 min, 0.9 min, and 2.3 min. B) 
Time-activity curves in the brain VOI (dynamic PET) and in arterial blood 
(automatic blood sampling). C) The one-tissue compartment model with three 
parameters K1, K2, and Vo, where K1 is an estimate of the CBF. The best fit of the 
model (black solid line) to the brain time-activity curve (open circles) using the 
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flow. 
Figure 10. The two figures show the individual StO2 values in percentage at the y-
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(35 mL/kg/min). 
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mL/kg/min); and pigs 6–8 (low blood flow 47.5 mL/kg/min).  
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CHAPTER 1. BACKGROUND 
 
1.1. CARDIOPULMONARY BYPASS 
In 1953, John Gibbon performed the first open-heart procedure (1), but first years 
later were a series of open-heart procedures performed using a modification of the 
Gibbon heart-lung machine (2). Today cardiopulmonary bypass (CPB) is used 
worldwide for cardiac surgery (3), and in the Western Region of Denmark CPB is 
used in 88% of all heart surgery procedures (4), with a 30-day mortality rate of 1.5% 
[95% CI 1.0–2.2%] after cardiac surgery (4). Although the mortality rate is low, 
complications still occur, e.g. severe bleeding, systemic inflammation response, 
stroke or neurocognitive dysfunction, and different degrees of multiorgan 
dysfunction and failure (3). The underlying mechanisms are highly complex and 
depend on several factors, e.g. patients’ comorbidity, embolic episodes, and periods 
of tissue hypoperfusion during CPB (5). During low flow conditions, the blood flow 
is distributed according to an organ hierarchy where the brain is of highest priority, 
then followed by the kidneys, the intestines, and finally the muscle tissues (6). The 
brain is protected by a strong autoregulation that keeps cerebral blood supply 
carefully titrated to the oxygen demand during both normal and low flow conditions 
(7). In contrast, muscle tissue blood flow is governed by central and humoral 
mechanisms leading to vasoconstriction and centralisation of the muscle blood flow 
to vital organs such as the brain (8). Muscle tissue acts as a reservoir of volume (8) 
that can be recruited, and therefore monitoring muscle tissue may serve as an early 
warning signal during low flow conditions. 
 
1.2. CALCULATED BLOOD FLOW DURING CARDIOPULMONARY 
BYPASS 
CPB acts as a mechanical and physiological substitute for the heart and the lungs 
and ensures oxygen delivery to all tissues (2, 9–10). A circular system with a roller 
pump or centrifugal pump delivers a non-pulsatile blood flow and an oxygenator 
provides a gas exchange of oxygen and carbon dioxide. The level of non-pulsatile 
blood flow during normothermic CPB is primarily calculated in litres per minute and 
based on the product of body surface area (BSA) and a constant of 2.4 (11–12). The 
most commonly used BSA formula was described by Dubois and Dubois in 1916, 
but is based on a very small sample size (12). The rationale for using BSA is that, on 
average, each square metre of the body mass has the same metabolic rate (11–12). 
The metabolic rate, and thereby the oxygen requirements, is primarily determined by 
lean tissue. In obese patients, a larger portion of the body mass is fat, and several 
studies have demonstrated that the Dubois formula is inaccurate in these patients 
(13–19). Recent studies (20–21) demonstrate that lean body mass (LBM) rather than 
BSA or body mass index (BMI) correlates with mixed venous saturation (SvO2) 
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during CPB (20), and in obese cardiac surgery patients fewer complications and a 
smaller number of blood transfusion are seen when ideal weight according to height 
is used to calculate BSA, indicating a more optimal blood flow during CPB (21).  
 
1.3. PATIENT POPULATION IN CARDIAC SURGERY 
Cardiac surgery is challenged by an increase in the elderly population in the Western 
world (22–23). Future cardiac surgery patients are therefore increasingly 
characterised by higher co-morbidities, in particular cerebrovascular disease, chronic 
obstructive pulmonary disease, left ventricular dysfunction, renal dysfunction, 
peripheral arterial disease, and diabetes mellitus (24–27). Indeed, increased 
comorbidities tend to be associated with a high rate of complications in cardiac 
surgery patients (24). Old age, previous stroke, hypercholesterolaemia, 
hypertension, and diabetes are all predictors of postoperative neurologic 
complications (25, 28–29).  
 
1.4. CEREBRAL AND MUSCLE PERFUSION  
To obtain an optimal CPB, blood flow is important because an insufficient blood 
flow leads to tissue hypoperfusion and thereby induces organ damage; on the other 
hand, hyperperfusion (too high blood flow) increases the risk of air embolism, the 
need of blood transfusion, and the development of a systemic inflammatory response 
(30-31). The following theories exist on how organ blood flow and hence tissue 
perfusion is governed: 1) The organ perfusion depends on arterial blood pressure 
and vascular resistance of the organ; 2) The distribution of blood flow to each organ 
is determined by the cardiac output (CO) because each organ receives a percentage 
of CO based on the organ’s metabolic needs; 3) The CPB produced blood flow is 
distributed due to an organ hierarchy where the brain is of first priority, then kidneys 
and intestines, and finally the muscle tissue, which has the lowest priority (6, 32). 
Cerebral blood flow (CBF) is regulated by powerful mechanisms in order to match 
cerebral metabolic demand and supply (32). It is presumed that a fluctuating blood 
pressure will not lead to changes in CBF if blood pressure is kept within the 
autoregulatory range of 50 to 150 mmHg (33). However, in a study in which a lower 
body negative pressure technique was used to imitate an acute decrease in central 
blood volume, an association between CO and CBF was demonstrated in young 
healthy subjects. Each percentage of change in CO corresponds to a 0.35% change 
in CBF, e.g. a 30% reduction in CO leads to a 10% reduction in CBF (34). A recent 
study in 31 healthy elderly subjects (35) failed to demonstrate an association 
between CO and CBF using magnetic resonance imaging techniques, but the study 
was done during rest and without any acute blood volume decrease. However, the 
study showed that when fractional CBF (total CBF/cardiac CO) is calculated, the 
fractional CBF is inversely correlated with cardiac index (CI (CO/BSA)), e.g. when 
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CI (and CO) decreases the fractional CBF will increase and the brain will receive a 
larger amount of CO. The peripheral regional blood flow of muscle tissue is also 
tightly regulated as it serves as a reservoir of volume during low CO. Indeed, muscle 
tissue has the ability to maintain its function even if oxygen delivery (DO2) is 
dramatically reduced (8). The blood flow to muscle tissue is governed by a vascular 
basal tone. An inhibitory stimulus to basal vascular tone induces a vascular 
vasodilatation, while an excitatory stimulus induces a vascular vasoconstriction (8). 
During low CO the most important regulatory mechanism is the central nervous 
system that activates baroreceptors and chemoreceptors, causing vasoconstriction 
and thereby a shunting of the blood flow from the periphery to the brain.  
 
1.5. OXYGEN DELIVERY DURING CARDIOPULMONARY BYPASS 
Besides the regulatory mechanism that governs organ specific blood flow, 
haemoglobin concentration and oxygen content are other factors influencing the 
DO2 to the tissues and thereby organ functions. If DO2 falls due to a decrease in 
blood flow, the extraction of oxygen from the blood will increase, but when a 
critical low DO2 is reached, a drop in tissue oxygen consumption (VO2) is seen, 
because the extraction of oxygen is limited. This phenomenon is characterised by a 
shift in the VO2-DO2 relationship from aerobic to anaerobic metabolism (36). In an 
experimental pig study using fluorescent microspheres (6), an organ-specific 
hierarchy of DO2 during CPB was demonstrated. The DO2 of the brain and kidneys 
was maintained at blood flows in the range 1.7 to 2.3 L/min/m2, in contrast to 
significant decreased DO2 in muscle tissue. These findings indicate that blood flow 
to the brain may be preserved at the expense of blood flow to the muscle tissue. It 
might also indicate that each organ has its own organ-specific critical DO2, so when 
the systemic critical DO2 value is reach, some organs may be well below their 
critical DO2, whereas others organs are above their critical DO2, as critical systemic 
DO2 presents the sum of all organ DO2 values.  
Individualised therapy has gained acceptance in many clinical specialties. It has 
been shown that postoperative complications after major surgery can be reduced by 
the use of individualised circulatory therapy (37). Cardiac surgery patients are 
characterised by increasing co-morbidities, age, and overweight, therefore there is a 
need for further refinement of CPB strategies by adapting CPB blood flows to 
individual patient needs. Nowadays, as mentioned above, the CPB blood flow is 
based on a calculation of BSA, but new monitoring technologies may help in the 
evaluation of systemic and regional perfusion and oxygenation and thereby the 
metabolism of regional tissues.  
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1.6. SYSTEMIC MONITORING 
The blood flow and perfusion pressure are interdependent during CPB. They are 
determined by arterial impedance, the degree of haemodilution, temperature, and 
arterial cross-sectional area. Changes in haemodilution and temperature are the most 
important determinants of DO2 and VO2 in tissues. VO2 can be assessed by 
continuous measurement of SvO2. SvO2 depends on several factors: 
SvO2 = SaO2 - (VO2 / (CO x (haemoglobin) x k) 
Where SaO2; arterial oxygen saturation and k a constant. The normal value for SvO2 
is > 65%. However during CPB, an SvO2 within the normal range does not 
guarantee sufficient oxygenation of all tissues as organ perfusion may be unevenly 
distributed (38). Indeed, during normothermic CPB, tissue hypoperfusion seems to 
be more accurately assessed by measuring serum lactate compared to measuring 
SvO2 (39). 
Hyperlactatemia is defined as blood lactate levels between 2–5 mmol/L without 
metabolic acidosis. Lactic acidosis occurs when lactate levels rise above 5 mmol/L 
together with metabolic acidosis (40). Indeed, when DO2 is limited, the majority of 
intracellular pyruvate is converted into lactate and hyperlactatemia develops (41). 
This is named type A lactate acidosis and typically occurs after initiating CPB, or 
within the first 24 hours of the postoperative period (41–42). It is relatively 
common, with an incidence of 10 to 20% in cardiac surgery patients using CPB (43-
44) and is associated with an increased risk of a complicated postoperative course 
with an 8- to 10-fold increase in mortality (44–46). Multiple factors contribute to the 
development of early hyperlactatemia (40), and the lactate clearance can be affected 
because of hepatic dysfunction (41). In a recent study, hyperlactatemia with a lactate 
> 3 mmol/L during CPB was associated with the need of a intra-aortic balloon 
pump, a longer duration of mechanical ventilation, and a longer length of stay in an 
intensive care unit (ICU) (47).  In general, the lactate to pyruvate ratio (LPR) is 
approximately 10:1, but lactate production can also occur with normal LPR, called 
type B lactate acidosis (42). Late-onset hyperlactatemia occurs in approximant 14-
20% of adult patients following cardiac surgery but is not associated with an 
increased risk of adverse events (40, 42). The pathophysiology behind late-onset 
hyperlactatemia is unclear (42).  
Both systemic parameters display obvious advantages, but also disadvantages.  SvO2 
is a fast reacting parameter, but it may overestimate oxygen delivery during low 
flow conditions due to centralisation of blood flow (38). Lactate is a more sensitive 
marker of tissue hypoperfusion but is late reacting and is not ideal for monitoring 
insufficient blood flow due to its slow elimination (41). Both systemic parameters 
are global parameters, and therefore they do not provide information about the 
underlying regional tissue perfusion during low blood flow conditions. 
 
9 
 
 
1.7. REGIONAL MONITORING 
1.7.1. Near-infrared spectroscopy 
Near-infrared spectroscopy (NIRS) is a non-invasive technique based on the 
transmission and absorption of near-infrared light as it passes through the underlying 
tissues. The infrared light penetrates tissue in several centimetres depth and is not 
attenuated by skin, bone, or other organs (48–49). The pioneer Jobsis discovered 
that metalloproteins (haemoglobin, myoglobin, and cytochrome c oxidase) acts as 
chromophores that absorb near-infrared light differently based on their concentration 
and state of oxygenation (oxy- or deoxygenated haemoglobin). Oxy-haemoglobin 
and deoxy-haemoglobin constitute the largest part of the chromophores (50), 
whereas the cytochrome c oxidase (a mitochondrial enzyme) only accounts for 2 to 
5% of the chromophores. However cytochrome c oxidase is responsible for more 
than 90% of cellular oxygen consumption because of its ATP production (48–49). 
The deoxy- and oxy-haemoglobin and cytochrome c oxidase absorb infrared light at 
different wavelengths: deoxy-haemoglobin 650–1000 nm, oxy-haemoglobin 700–
1150, and cytochrome oxidase aa3 at 820–840 nm (49). The NIRS devices use 
multiple wavelengths and calculate the tissue’s optical density at each wavelength 
based upon the reflected light. The calculation is based on a modification of the 
Beer-Lambert Law (50–51). The NIRS devices use wavelengths between 700 and 
850 nm (INVOS 730 and 810 nm) because the wavelengths of total haemoglobin 
and oxy-haemoglobin are clearly separated, thereby calculating regional tissue 
saturation (52). The NIRS light transmission is an elliptical distribution. The mean 
depth is proportional to the separation of the optodes by a factor of approximately 
1/3 (53). If the optode distance is increased, the depth of penetration increases, and 
the signals from the extra-cerebral tissue decrease, improving the NIRS signal. 
However, increasing optode distance increases the risk of direct thermal tissue 
damage (53). The maximal optode distance is 5 cm, resulting in penetration depth of 
approximately 2 cm (53). To improve the NIRS signal, two receiving optodes can be 
used. The closer receiver optode (e.g. 3 cm separation) detects the NIRS signal from 
superficial tissue, whereas the more distant receiver optode (e.g. 4 cm separation) 
detects the NIRS signal from deeper tissue. A built-in subtraction algorithm enables 
calculation of the deeper tissue saturation (53). The NIRS signal reflects the oxygen 
balance in small vessels below 1 mm in diameter, because larger vessels contain 
large concentration of iron containing heme groups that absorbs all infrared light 
(52). 
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Figure 1. The image demonstrating a schematically cross-section of the brain with 
NIRS sensor placed over the frontal lobe bilaterally. The NIRS optode transmits 
infrared light in elliptical distribution through the extracranial tissue and brain tissue. 
The reflected NIRS signal is collected by the two receiver optodes. The closer 
receiver detects the NIRS signal from the extra-cranial tissue, whereas the distant 
receiver detects the NIRS signal from deeper tissue, e.g. brain tissue. 
Despite the built-in subtraction algorithm, extra-cranial tissue influences the NIRS 
signal as demonstrated in a study where three different NIRS devices were tested 
(54). In healthy persons, a pneumatic head cuff was inflated. Indeed, after 5 min 
(post-inflation) a decrease in NIRS signal was seen from baseline for INVOS mean 
decrease 16.6%, SD ± 9.6% (P = 0.0001), FORE-SIGHT mean decrease 11.8%, SD 
± 5.3% (P < 0.0001), and the EQUANOX mean decrease 6.8%, SD ± 6.0% (P = 
0.0025). The authors concluded that extra-cranial tissue appears to significantly 
influence the regional cerebral tissue oxygen saturation (rSO2) measured with NIRS. 
Other studies have indicated that the use of vasoconstrictive agents influence extra-
cerebral tissue and thereby rSO2 (55–58). Another study has shown that muscle 
tissue oxygenation saturation (StO2) is influence by body surface cooling in healthy 
persons (59). The main mechanism was vasoconstriction, but the study did not allow 
any conclusion regarding whether skin or muscle tissue is the major contributor to 
the changes in StO2. A recent study (60) investigated the effect of normothermic 
(36.6 C) versus hypothermic CPB (32 C) on the rSO2 signal in cardiac surgery 
patients. rSO2 values were significantly higher during normothermic CPB, but SvO2 
values were lower compared to hypothermic CPB. No explanation could be given. 
The NIRS signal is also influence by melanin pigmentation found in hair, which 
weakens the infrared light transmission. This is in contrast to melanin in the skin, 
which is located in the epidermal layer (50–100 µm) (61). Another concern is that 
haemoglobin and myoglobin share similar optical properties. Myoglobin may 
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therefore influence StO2 values. Myoglobin has a higher affinity for oxygen than 
haemoglobin; therefore myoglobin will have high oxygen saturation during tissue 
hypoperfusion and result in StO2 overestimated (61). NIRS devices also show intra-
individual and inter-individual variability in baseline rSO2 (52). In cerebral and 
muscle tissue, the average distribution of arterial/venous ratio is 30% arterial and 
70% venous (52), but there is a considerable biological variation in arterial/venous 
ratios between patients. All NIRS monitors have predefined arterial/venous ratios 
(INVOS 25%/75%) therefore a trend monitoring is more appropriate. Indeed, the 
different NIRS devices have different solutions to these technological challenges 
that make it difficult to compare studies. Last but not least, the single-use NIRS 
sensors are relatively expensive, so cost-benefit analysis may also be considered 
before routine clinical application (62). 
 
1.7.1.1. Near-infrared spectroscopy of the brain in cardiac surgery 
During cardiac surgery rSO2 sensors are placed on the patient’s forehead covering 
the so-called watershed area (the area receiving blood from the anterior and medial 
cerebral arteries), thus reflecting the oxygen balance in the grey cortex (63). Murkin 
et al. (64) conducted a prospective randomised study in which patients were 
randomised to an intervention group (n = 100), where intraoperative measured rSO2 
was kept above 75% of preoperative baseline values (INVOS) using an intervention 
protocol, while the non-intervention group underwent blinded rSO2 monitoring 
(control, n = 100) without intervention. The stroke incidence was insignificant 
between the groups, but the patients in the no intervention group died or developed 
organ morbidity significantly more often than those in the intervention group. The 
no intervention group had a lower baseline and mean rSO2 values, and an increased 
number of episodes of intraoperative cerebral desaturation. Also longer ICU stay 
and hospital length of stay were demonstrated in the non-intervention group. In 
another prospective randomised study including 265 coronary artery bypass grafting 
(CABG) patients (65), the intervention group received active treatment if rSO2 
decrease more than 20% from baseline compared to the non-intervention group. 
Mean rSO2 values were 58% and 61% in the intervention and control group, respec-
tively. In the intervention group, rSO2 was not restored in all patients. The incidence 
of postoperative cognitive decline was assessed by a neurocognitive and 
neuropsychological examination but no difference was found. In a post hoc analysis, 
a prolonged cerebral desaturation time was defined as rSO2 score greater than 
3.000%/second, meaning an rSO2 value below 50% for 3000 seconds or more. A 
prolonged cerebral desaturation >3000% seconds was associated with postoperative 
cognitive decline and extended hospital length of stay. However, because treatment 
was initiated to reverse desaturation after the rSO2 threshold had been reached, it 
may be that potential benefits are obtained from the rapid intervention and reversal 
of cerebral desaturation. This theory is supported by an animal study (66), and in a 
prospective observational study of cardiac surgery patient using CPB (67) in which a 
lowest value of rSO2 below 35% or the areas under the curve of rSO2 below 40% for 
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more than 10 minutes significantly increased the incidence of neurological events 
determined by neurologic tests. Heringlake M et al. (68) designed a prospective 
observational study of 1178 patients undergoing cardiac surgery. A low preoperative 
rSO2 was significantly correlated with postoperative biomarkers of both cardiac and 
renal injury, and with preoperative cardiac dysfunction (ejection fraction <30%). 
rSO2 was lower in patients who had died by day 30 compared with those who 
survived, and the preoperative rSO2 <50% was an independent risk factor for 30-day 
and 1-year mortality. The authors suggest that preoperative rSO2 could be a sur-
rogate marker of other organ perfusion, and rSO2 may be of use as in risk 
stratification of patients undergoing cardiac surgery. 
 
1.7.1.2. Near-infrared spectroscopy of muscle tissue 
StO2 has been well studied in trauma patients. Crookes et al. (69) conducted a 
prospective observational study that includes normal human volunteers (n = 707) 
and patients admitted to a Level I trauma centre (n = 150). Using the In-Spectra 
tissue spectrometer, they establish the normal ranges of thenar StO2  (mean 87%, SD 
± 6%). In addition, the thenar StO2 was able to discriminate the no shock patients 
from patients with severe shock. Likewise, thenar StO2 values were able to predict 
those who survived and those who did not survive at an early stage. Indeed, they 
correlated a 10% decrease in thenar StO2 to an increase in mortality using an In-
Spectra device (70). If the trauma patient was able to maintain StO2 above 75%, 
there was a high probability of not developing organ dysfunction or death after 
severe trauma (71–72). In cardiac surgery, StO2 has been investigated in the 
perioperative setting using CPB. In the perioperative period conflicting results 
exists, as StO2 does not correlate with global systemic parameters (73–74). 
However, using CPB, StO2 declined by 13%, with a delayed increase in lactate and 
base deficit. Interestingly, the minimum muscle StO2 value preceded the maximum 
lactate level by an average time of 94 min, suggesting that StO2 measured with In-
Spectra identifies hypoperfusion much earlier than conventional metabolic markers 
during CPB (75).  
 
1.7.2. Validation of near-infrared spectroscopy 
Regional cerebral tissue oxygen saturation (rSO2):  
Clinical validation and cerebral ischaemic thresholds for rSO2 are derived from 
retrospective studies involving patients for carotid endarterectomy (CEA) in which 
rSO2 is compared using clinical neurologic examinations (76). During anaesthesia 
for CEA, 10 of 99 patients developed neurologic symptoms, and they had a 
significantly greater reduction in rSO2 from baseline (rSO2 > 20%). In a larger study 
using general anaesthesia for CEA, a much smaller reduction of 11.7% from 
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baseline was identified as predictor of postoperative neurologic symptoms (77). 
Indeed, both studies demonstrate that a reduction in baseline less than 20% seldom 
results in neurologic complications, but on the other hand, a decrease below 20% 
may not necessarily cause neurologic complications (76-77). Today, there is no 
definition of what is a critical decrease in rSO2 from baseline that correlated with or 
leads to postoperative neurologic symptoms after cardiac surgery. However, the 
most common ischaemic thresholds for rSO2 during cardiac surgery are obtained 
from the above-mentioned studies even though anaesthetics and temperature differs 
in cardiac surgery. A previous study (68) demonstrated rSO2 values in room air 
mean 62%; cardiac patients inspired 100% oxygen mean rSO2 66%; and increasing 
rSO2 values compared to preoperative rSO2 when anaesthetised with total 
intravenous anaesthesia or sevoflurane (68, 78). During cardiac surgery, the rSO2 
ischaemic threshold is a 20% reduction from baseline or an absolute rSO2 value 
below 50% (62). The “normal” cerebral range lies between 60% and 75%, with a 
variation of approximately 10% for absolute baseline values (79). 
Regional muscle tissue oxygen saturation (StO2):  
The StO2 measured with NIRS has been validated in in vitro studies (80), in animal 
models (81–82), and in studies in humans. In a human study, muscle oxygenation 
and venous saturation of the forearm was closely related during exercise, and muscle 
oxygenation level decreased or increased with an intravascular administration of 
norepinephrine and nitroprusside, respectively (83). Indeed several studies 
demonstrate that StO2 correlates with venous blood in the underlying tissue (84–87), 
but only if the venous blood sampled represents the tissue region studied by NIRS. 
StO2 may also reflect muscle blood flow. Using NIR1000 and recording forearm 
StO2 values during different inspired oxygen fraction, the forearm muscle blood 
flow was calculated from the obtained StO2 values using complex calculations. The 
NIRS calculated forearm blood flow was compared with muscle blood flow 
measured with venous occlusion plethysmography (R2 = 0.95) (87). Furthermore, in 
a complex study muscle VO2 measured with NIRS (88) showed a good correlation 
with forearm muscle blood flow measured by strain-gauge plethysmography (r = 
0.93).  
Multiple peripheral sites for measuring StO2 are possible, but only the thenar 
eminence and the forearm have been validated (89). Traditionally, the thenar 
eminence is used due to the minimal fat layer, minor inter-individual variation, and 
the lesser risk of systemic oedema. The disadvantage of using the thenar eminence is 
the difficult fixation of the sensor (89). The forearm is a predominant site of 
vasoconstriction during low CO, so the vascular response may be earlier and more 
marked (90–91). Indeed, a previous study demonstrated that the forearm StO2 is 
more sensitive than the thenar StO2 in detecting hypovolemia (92). Alternative 
measurement sites for StO2 are pectoral muscle, deltoid muscle, vastus lateralis 
muscle, and the paravertebral region (93–94). The disadvantage of these sites is that 
they represent more central measurement sites and therefore they may be less 
sensitive in detecting vasoconstriction.  
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1.8. ADVANCED REGIONAL MONITORING 
1.8.1. Microdialysis 
Microdialysis is designed to mimic a blood capillary and is used for continuous 
measurement of biomarker concentrations in the extracellular fluid of tissues (95). 
The measured biomarkers of microdialysis are glucose, pyruvate, lactate, and 
glycerol (96). As blood flow decreases the regional metabolism changes. Initial 
glucose delivery to the tissue decreases with decreasing blood flow, and as the cells 
use the available glucose, the glucose concentration in the interstitial tissue will 
decrease. During anaerobic metabolism, pyruvate is converted into lactate, shifting 
the equilibrium towards lactate. The LPR thereby reflects whether metabolism is 
determined by an aerobic or anaerobic mechanism. During severe anaerobic 
conditions, the decreasing ATP production and pH decrease, leading to enzyme 
failure. Finally, degradation of cell membranes leads to a release of phospholipids 
that are converted into glycerol and free fatty acids, which accumulate in the 
extracellular tissue fluid. Therefore, increased levels of glycerol measured by 
microdialysis fluid may indicate cell membrane disintegration due to ischaemia (97-
99). Measuring biomarkers concentration may indirectly indicate whether the 
regional metabolic blood flow is sufficient. 
Several limitations must be remembered when microdialysis is used. It has been 
shown that implantation of a microdialysis catheter can disturb microcirculation, 
rate of metabolism, or physiological barriers, such as the blood–brain barrier (99). It 
is important that sufficient time is allowed after insertion of the microdialysis 
catheter for recovery and establishment of a new steady state. Another important 
consideration is to distinguish between the absolute recovery and the relative 
recovery. The absolute recovery is the amount of substance obtained in the dialysate. 
The relative recovery is the ratio between the concentration of dialysate and the 
concentration in the tissue. The tissue and dialysate concentrations may be different 
because the equilibration over the membrane is not complete. The absolute and the 
relative recovery are inversely related to each other and to the flow rate, as seen in 
Figure 2.  
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Figure 2. The absolute and relative recovery time as a function of flow rate. 
The highest absolute recovery is obtained by high flow rate, but will in addition 
result in dilution of the dialysate and reduced concentration of the biomarker. The 
relative recovery is largely dependent on the flow rate: the lower the flow rate, the 
higher the recovery. However, in practice the flow rate cannot be decreased too 
much since the sample volume obtained for analysis will be too small. The collected 
biomarkers contain a mean concentration during a sample interval, and therefore it is 
the relative changes in concentrations that are relevant (95). Furthermore, the 
microdialysis results reflect regional metabolism, but with a time delay in proportion 
to the perfusion rate, length of connecting tubes, and the time applied for analysis of 
the dialysate, which must be taken into account when interpretation the 
microdialysis results.  
 
1.8.2. DYNAMIC POSITRON EMISSION TOMOGRAPHY 
Dynamic positron emission tomography (PET-CT) scan uses a short-lived 
radioactive tracer that is inhaled or injected into the blood circulation (100). After an 
equilibrium period, the injected radioactive tracer becomes concentrated in tissues of 
interest. During the following scan, a record is made of the tissue concentration as 
the tracer decays. Thereafter a resulting map is constructed showing the tissues in 
which the radioactive tracer has become concentrated (Figure 2a). Further image 
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analysis and kinetic modelling result in calculation of regional tissue perfusion of 
brain and muscle tissue (Figure 2bc). Limitations to the widespread use of PET-CT 
arise from the high costs of cyclotrons needed to produce the short-lived 
radionuclides for PET-CT scanning and the need for a special setup for handling 
radioisotope preparation. In addition, during PET-CT scanning, the radiation 
exposure is around 23–26 mSv (101). In comparison, the radiation dosage for chest 
x-ray is 0.02 mSv and for CT scan of the chest 6.5–8 mSv (102).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Flow process diagram of handling PET images in study IV. A) Selected 
slices from the dynamic PET scan following H215O injection. The volume-of-interest 
(VOI) is shown in red and is made up of regions drawn in adjacent slices. The four 
sets of slices correspond to time points t = 0.3 min, 0.6 min, 0.9 min, and 2.3 min. B) 
Time-activity curves in the brain VOI (dynamic PET) and in arterial blood 
(automatic blood sampling). C) The one-tissue compartment model with three 
parameters K1, k2 and Vo, where K1 is an estimate of CBF. The best fit of the model 
(black solid line) to the brain time-activity curve (open circles) using the arterial 
time activity curve. 
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1.8.3. BRAIN OXYGENATION 
Oxygen tension in brain tissue (PbtO2) is measured with a Licox microcatheter that 
uses a polarography technique (a Clark electrode) to measure the oxygen tension. 
PbtO2 reflects both the perfusion and diffusion characteristics of oxygen in brain 
tissue (103). PbtO2 is affected by several factors: partial pressure of arterial oxygen 
(PaO2), partial pressure of arterial carbon dioxide (PaCO2), CBF, intracerebral 
pressure (ICP), cerebral perfusion pressure (CPP) and diffusion time, (103) and, 
haematoma formation and tissue oedema. A normal PbtO2 value obtained in animal 
studies is in the range of 25 to 30 mmHg (104), and PbtO2  <  10 mmHg has been 
associated with ischaemic CBF thresholds, and a decrease in jugular venous 
saturation below the critical threshold of 50% correlated with a brain PbtO2 of 8.5 
mmHg (105).  
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CHAPTER 2. OVERALL AIM AND 
HYPOTHESIS 
 
The overall aim of the PhD thesis was to investigate tissue metabolism of the brain 
and muscle using cerebral NIRS (human study) and muscle NIRS (experimental 
study) and evaluate the measurement with more advanced regional monitoring 
methods, i.e. microdialysis and PET-CT during low blood flows using CPB, thereby 
gaining insight into the extreme ends of the organ hierarchy during hypoperfusion. 
 
2.1. HYPOTHESES 
Study I 
We hypothesised that cerebral perfusion is preserved during CPB at blood flows 
equalling the cardiac index measured prior to CPB evaluated by cerebral NIRS 
during CPB. 
Study II 
We hypothesised that StO2 measured with NIRS 1) is a fast-reacting indirect 
indicator of global hypoperfusion during CPB and 2) follows the changes in 
systemic acid/base balance and in metabolism in remote organs.  
Study III 
We hypothesised that changes in muscle tissue perfusion measured with PET-CT 
would be reflected by parallel changes in StO2 measured by NIRS. 
Study IV 
We hypothesised that CPB produced blood flow is the main determinant of cerebral 
perfusion compared to mean arterial blood pressure for cerebral perfusion during 
normothermic and normocapnic low flow CPB.  
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CHAPTER 3. MATERIALS AND 
METHODS 
 
3.1. STUDY DESIGN 
Study I design 
Twenty-two adult patients scheduled for elective cardiac surgery were included. All 
cardiac surgery patients had a left ventricular ejection fraction > 50%, no history of 
cerebral insult, head trauma, or verified carotid artery stenosis. A randomised 
crossover study was performed, where blood flow during normothermic CPB for 20 
minutes was based on either the calculated flow (2.4 L/min/m2) or the individual 
thermodiluted measured CI prior to CPB, and then a switch to the alternative blood 
flow for another 20 minutes. After the last study period, the CPB blood flow was 
adjusted to the standardised 2.4 L/min/m2. During the two different blood flows, 
systemic parameters and bilateral rSO2 were measured. 
 
Figure 4. The flow chart in study I. 
Study II design 
Twelve pigs (80 kg) were anesthetised and normothermic CPB was established at 60 
mL/kg/min, thereafter blood flow was reduced to either 47.5 mL/kg/min (Group I) 
or 35 mL/kg/min (Group II) for another hour and finally returned to a blood flow of 
60 mL/kg/min for 1 hour. StO2 and microdialysis were performed in the musculus 
gracilis of the non-cannulated leg, and microdialysis was performed in intestinal 
tissue and brain tissue in addition to Licox measurements of the brain at each blood 
flow. 
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Figure 5. Flow chart in study II. 
Studies III and IV design 
Eight pigs (69–71 kg) were anesthetised and baseline PET-CT was performed. The 
animals were connected to normothermic CPB with a blood flow of 60 mL/kg/min 
for 1 hour, thereafter blood flow reduction to either 47.5 mL/kg/min (Group I) or 35 
mL/kg/min (Group II) for another hour and finally returned to a blood flow of 60 
mL/kg/min for 1 hour. PET with 15O-labelled water was performed to evaluate the 
blood perfusion in muscle tissue (study III) and cerebrum (study IV) during each 
blood flow. 
 
Figure 6. Flow chart in studies III and IV. 
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3.2. MONITORING METHOD 
In the four studies, systemic and different regional measurements were used to 
evaluate tissue perfusion, oxygenation, and metabolism during normal (study I) and 
low CPB blood flows (studies II–IV), with emphasis on cerebral and muscle tissue.  
 
3.2.1. MONITORING METHODS STUDY I 
Systemic oxygen consumption was estimated as arterial and venous blood samples 
and withdrawn every 5 minutes during the 20 minutes of each study period and 
analysed. Mean arterial blood pressure (MAP), SvO2, and CI were recorded at the 
same time. The regional rSO2 was measured with NIRS (INVOS 4100) continuously 
using sensors placed bilaterally on the patient’s forehead prior to the induction of 
general anaesthesia. Cerebral oximeter readings were recorded and stored. 
 
3.2.2. MONITORING METHODS STUDY II 
The muscle tissue oxygen balance was estimated by continuously StO2 
measurements with NIRS (INVOS 5100). The sensor was placed on the skin above 
the musculus gracilis of the non-cannulated back leg. In addition, a microdialysis 
catheter (CMA 60, CMA Microdialysis AB, Solna, Sweden) was inserted into the 
musculus gracilis through a skin incision next to the NIRS sensor. Tissue perfusion 
was performed with a physiologic solution (CMA perfusion fluid) at a pump flow 
rate of 1.0 µL/min (CMA 102, CMA Microdialysis AB, Solna, Sweden). The 
muscle tissue CMA60 catheter has an inner diameter of 15 mm, a 20 mm shaft, and 
a 105 mm outlet tube. The calculated dead space is 0.18 µl per cm outlet tube. No 
adjustment for time delay was done, as the dead space time of 2.25 minutes was 
considered low compared to the total sampling time (20 minutes).  
Systemic parameters (arterial and venous blood samples), regional brain 
microdialysis and PbtO2, and regional microdialysis of intestinal colon were used to 
evaluate the level of ischaemia during the two low blood flows. A microdialysis 
catheter was inserted into the brain (CMA 70 brain, CMA Microdialysis AB, Solna, 
Sweden) and the intestinal tissue of the colon thorough a drill hole and mini-
laparotomy, respectively. One hour of dialysis was performed to obtain a steady 
state in all tissues, and the dialysates were discarded. During the study period, 
dialysates were collected in vials every 20 minutes. Vials were maintained at 4ºC 
during the study period and finally stored at -80ºC until analysed for glucose, lactate, 
pyruvate, and glycerol (CMA 600 Microdialysis Analyser, CMA Microdialysis AB, 
Solna, Sweden). No adjustment for time delay was done during brain and intestinal 
sampling. The CMA microdialysis catheter for the brain was specified with a cutoff 
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at 20,000 Daltons and a membrane length 10 mm, and the CMA microdialysis 
catheters for the intestinal mucosa and muscle tissue were specified with a cutoff at 
20,000 Daltons and a membrane length 30 mm with a flow rate of 1.0 µl/min. In our 
study, the relative recovery was not determined.  
Cerebral NIRS could not be measured due to the thickness of the porcine skull of > 
4 cm thick. Instead, a Licox microcatheter was inserted through a drill hole, and 
PbtO2 and temperature were recorded every 20 minutes (Licox CMP Monitoring 
System Integra Neurosciences, Plainsboro, NJ, USA). 
 
3.2.3. MONITORING METHODS IN STUDY III AND STUDY IV 
In studies III and IV, PET was performed by a Siemens Biograph 64 Truepoint 
PET/CT camera (Siemens AG, Erlangen, Germany) following a PET/CT scan 
protocol which consisted of: 1) a topogram, 2) a CT scan, and 3) a 5-min PET list-
mode scan after 500 MBq H215O intravenous injection. After each PET scan, a 
period of at least 6 half-lives (12 min) was allowed for the previous tracer to decay. 
During the PET acquisition, arterial blood was sampled repeatedly, and radioactivity 
was measured every 0.5 s by use of an automatic blood sampler connected to the 
right carotid artery branch (Allogg AB, Mariefred, Sweden). Dynamic PET data and 
arterial blood data were corrected for radioactive decay from the start of the tracer 
administration. Using fused PET/CT images, regions-of-interest (ROIs) were drawn 
in muscle tissue (study III) and brain (study IV). For each dynamic scan (H215O), 
ROIs were defined in adjacent transaxial slices of an image of the mean 
radioactivity concentration. The NIRS sensor was identified at the muscle surface, 
and ROIs were draw precisely beneath the sensor at levels 1–2 cm, 2–4 cm, and 4–6 
cm (study III). Likewise ROIs were drawn of the brain with no differentiation 
between the grey and the white substance (study IV). The ROIs were summed to a 
volume-of-interest (VOI) from which the time course of muscle tissue (study III) 
and brain (study IV) concentration of H215O was generated. Tissue blood perfusion 
was estimated by fitting the one-tissue compartment model to the muscle time-
activity curve (dynamic PET) using the arterial input function (blood samples). In 
this way, robust fits were obtained using three parameters (blood perfusion, blood 
volume, and time delay) and fitting only the early 2 minutes of PET data. The non-
linear regressions were made using in-house developed software iFit 
(www.liver.dk/ifit.html).  
The systemic oxygen consumption was estimated by arterial and venous blood 
samples withdrawn every 15 minutes. In study III, StO2 was measured with NIRS 
(INVOS 5100) continuously using sensors placed on the skin above the musculus 
gracilis of the non-cannulated back leg. In study IV, rSO2 could not be measured due 
to the thickness of the porcine skull, i.e. > 4 cm thick. 
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3.3. STATISTICS 
In study I, a linear mixed effects model (LME) that included fixed and random 
effect analysis was used to examine the change of biomarkers over time in the two 
treatment groups (calculated cardiac index group and individual thermodiluted 
measured cardiac index group). All data were tested for normal distribution. Non-
normal distributed data were log-transformed to achieve normality before further 
statistical analysis. Parametric statistics were used for normally distributed data. 
Results shown as mean +/- SD. P-values less than 0.05 were considered statistically 
significant. The model was implemented and analysed with statistical software 
package R, Version 2.9.18 (using the contributed package nime for mixed effects 
modelling). 
In studies II-IV, a non-parametric statistical method was used. Values were giving as 
median (25–75 percentiles), and each pig served as its own control.  
In study II, the Wilcoxon-Mann Whitney test was used to compare the baseline 
values between the groups. Friedman test was performed for each parameter at 60 
minutes during each period in the two groups to estimate a significant level from 
baseline during the different blood flows.  
In study III, the relationship between StO2 and muscle blood flow was described by 
nonlinear regression using the Global Curve Fitting (Sigma plot 12.5, Systat 
Software Inc., San Jose, CA, USA) and the R2 was reported.  
In study IV, individual cerebral tissue perfusion and MAP, haemoglobin, and PaCO2 
values were compared during the course of the experiment using Spearman’s 
correlation analysis.  
Statistical analyses were performed using Stata® (version 14.0), and the level of 
significance was set at p <0.05. 
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CHAPTER 4.  SUMMARY OF RESULTS  
 
4.1. STUDY I 
Mean individual blood flow (measured prior to the CPB) versus the calculated blood 
flow was 2.1 L/min/m2 and 2.4 L/min/m2 (Figure 7), respectively. In both study 
periods, the SvO2 was >60 %, base excess 3–4 mmol/L and lactate less than 2.0 
mmol/L. There were no differences between the groups regarding CI, MAP, 
rSO2left, rSO2right, or SvO2.  
 
Figure 7. The two figures show rSO2 values measured with NIRS at the y-axis 
during calculated cardiac index of 2.4 L/min/m2 (left figure) and individual cardiac 
index (right figure). 
 
  4.2. STUDY II 
The systemic parameters demonstrated systemic ischaemia with a significant 
decrease in SvO2 (Group I: p =0.02, Group II: p =0.01) and an increase in serum 
lactate in Group II (p =0.01) during low blood flow. The intergroup differences were 
also significant (SvO2: p =0.02, lactate: p =0.01). However, in Group II, SvO2 
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increased and was almost normalised during reperfusion in contrast to lactate 
(Figure 8).  
 
 
Figure 8. Time course of SvO2 and lactate measured every 20 minutes at each blood 
flow. Blood flow of 60 mL/kg/min2 from 0–60 minutes, low blood flow from 80–
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120 minutes, and re-established blood flow of 60 mL/kg/min2 from 140–180 
minutes. 
The StO2 showed only minor changes in Group I (p =0.06), but in Group II a 
significant decrease (p =0.01) during the low flow period was seen (Figure 9). 
During reperfusion, StO2 increased; however, the increase was less pronounced in 
Group II. The decrease in StO2 occurred rapidly within the first 5 minutes, as seen in 
Figure 10. A significant correlation was seen between SvO2 and StO2 (Spearman; r: 
0.29, p <0.005) and between lactate and StO2 (Spearman; r: -0.35, p <0.001).  
Changes in the metabolites in muscle tissue corresponded with muscle StO2 values; 
In Group II significant changes were seen for muscle pyruvate and muscle glycerol, 
as no changes occurred in Group I. No correlation could be demonstrated between 
blood lactate and LPR of muscle. Likewise, changes in intestinal and brain tissue 
metabolites paralled muscle StO2. However, PbtO2 did not change significantly.  
 
One pig (Group I) was excluded due to severe blood loss during preparation for 
CPB, and the StO2 values were missing in one pig (Group I) due to technical 
problems wit h the equipment.  
 
Figure 9. The two figures show the individual StO2 Group I (47.5 mL/kg/min (left 
figure)) and Group II (35 mL/kg/min (right figure)) during the time course of the 
study. The dark grey zone resembles the blood flow of 60 mL/kg/min and re-
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established blood flow of 60 mL/kg/min, and the light grey zone resembles low 
flow. 
 
Figure 10. The two figures show the individual StO2 values in percentage at the y-
axis 5 minutes before blood flow reduction to low blood flow and 5 minutes after 
initiating low blood. Left figure Group I (47.5 mL/kg/min) and right figure Group II 
(35 mL/kg/min). 
 
4.3. STUDY III 
Systemic ischaemia was demonstrated during the two low flow periods. Muscle 
tissue perfusion was measured at three different depths, 1–2 cm; 2–4 cm, and 4–6 
cm, in the hind limb skeletal muscle. Accordingly the StO2 was measured over the 
same region. Muscle tissue perfusion was high before initiating CPB but decreased 
during CPB according to the CPB blood flow (Figure 11). Indeed, StO2 remained 
high until the muscle tissue perfusion had decreased to about 50%, after which StO2 
almost linearly followed the fall in muscle tissue perfusion. There was an excellent 
non-linear relationship between the normalised values for muscle tissue perfusion 
and StO2, with an R2 of 0.85 (p <0.00001) (Figure 12). 
In studies III and IV, two pigs had complications; 1) One animal due to severe 
bleeding from a nasal temperature probe (#4); 2) one animal due to technical 
problems with dynamic PET (#5). 
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Figure 11. Muscle tissue perfusion in % of baseline (spontaneous circulation) 
during the different CPB blood flows. Pigs 1–3 (low blood flow 35 mL/kg/min); pig 
4 prolonged low flow (47.5 mL/kg/min); pig 5 profuse bleeding from the nose (47.5 
mL/kg/min); and pigs 6–8 (low blood flow 47.5 mL/kg/min).  
 
Figure 12. The relationship between normalised muscle blood perfusion obtained by 
PET and StO2 obtained by NIRS. The line depicts the best fit.  
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4.4. STUDY IV 
Initiating blood flow of 60 ml/kg/min from spontaneous circulation increased CBF 
(Figure 13). Furthermore, CBF and CPB pump flow were positively related (R2 = 
0.37), while CBF and MAP showed an inverse relationship (R2 = 0.30). No relation 
between CBF and haemoglobin (R2 = 0.01) or CBF and PaCO2 (R2 = 0.03) was 
found. rSO2 was not measured due to the thickness of the pig’s skull. 
 
Figure 13. CBF in % of baseline (spontaneous circulation) during the different CPB 
blood flows. Pigs 1–3 (low blood flow 35 mL/kg/min); pig 4 prolonged low flow 
(47.5 mL/kg/min); pig 5 profuse bleeding from the nose (47.5 mL/kg/min); and pigs 
6–8 (low blood flow 47.5 mL/kg/min).  
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CHAPTER 5. DISCUSSION 
 
In clinical practice, systemic measurements of haemodynamics are used as a 
surrogate marker to assess regional perfusion and hence tissue oxygenation and 
metabolism. The main disadvantage of systemic haemodynamic measurements is 
that they are global assessments, and require invasive techniques (38, 41) therefore 
time-consuming for early detection of shock states (106). Measurement of regional 
tissue perfusion, oxygenation balance, or metabolism has several advantages. In 
early stages of shock, blood flow is recruited from peripheral tissues (muscle tissue) 
to vital organs (brain tissue) (6, 8), therefore monitoring perfusion in peripheral 
tissues could be an early marker of systemic hypoperfusion (90–91). Furthermore, 
peripheral tissues are easy to monitor using non-invasive techniques thereby 
facilitating earlier initiation of monitoring (106).  
The overall aim of the PhD thesis was to investigate tissue metabolism of brain and 
muscle using cerebral NIRS (human study) and muscle NIRS (experimental study) 
evaluated by more advanced techniques, thereby studying both extremes (brain and 
muscle tissue) of of the well-defined organ hierarchy during low CPB blood flows. 
The main findings were that (1) during short period of CPB, a cardiac index of 1.9–
3.1 L/min/m2 is sufficient to sustain cerebral oxygenation measured with cerebral 
NIRS in cardiac surgery patients; (2) during CPB mediated inadequate systemic 
circulation StO2 decreased and indicated insufficient global tissue perfusion even 
when systemic circulation was restored after a period of systemic hypoperfusion in 
an experimental animal model; (3) during CPB mediated inadequate systemic 
circulation StO2 remained high until muscle blood flow had decreased to about 50%, 
after which StO2 almost linearly followed the fall in muscle blood flow in an 
experimental animal model; (4) and during normocapnic and normothermic CPB, 
pump flow is a main determinant of cerebral perfusion compared to MAP during 
low blood flow in an experimental animal model.  
 
5.1. STUDY I 
Cardiac surgery patients are characterised by high co-morbidity (24-27), age (22-
23), and weight (20-21). Consequently it is increasingly important to tailor optimal 
treatment for the individual patient (37). As early as 1959, Gollan et al. suggested 
SvO2 as an individual guidance for blood flow requirements during CPB (107). 
Indeed, a recent study used SvO2 to tailor individual therapy and showed that 
keeping SvO2 above 75% led to a better preserved DO2 than BSA based blood flow 
(108). In study I, the BSA-based blood flow was compared to an individualised CI 
(patient’s own measured CI prior to CPB) showing that the blood flow during 
normothermic CPB is safe at a wider range than the recommended (3) blood flow of 
2.2–2.5 L/min/m2. In fact, the present study showed that during elective heart 
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surgery patients with a normal LVEF, an individual CPB flow of 1.9 L/min/m2 to 
3.1 L/min/m2 resulted in cerebral and global oxygenation similar to that of CPB flow 
based on BSA. Only a few studies have challenged BSA calculated blood flow (20, 
21,108). However, in hypothermic cardiac surgery patients (109), an increase in 
blood flow from 2.5 L/min/m2 to 3.0 or a decrease from 2.5 L/min/m2 to 2.0 
L/min/m2 led to an increase or a decrease in rSO2, respectively. Restoring MAP with 
phenylephrine made rSO2 decrease even further at a blood flow 2.0 L/min/m2 (109). 
Comparing the later study (109) with our study is difficult due to different study 
designs. In our study, we compared calculated blood flow with individual blood 
flow, so some cardiac surgery patients were above and others below the calculated 
blood flow during the individual blood flow period. Furthermore, in our study I the 
rSO2 values were compared over 20-minute periods, whereas in the later study 
(109), rSO2 was measured 5 minutes after blood flow change. Other factors that 
might have caused the conflicting results are the use of hypothermic CPB, as 
hypothermia is known to cause vasoplegia and to influence CBF (110). In addition, 
hypothermia also induces vasoconstriction of the skin that might influence the rSO2 
values (110). Furthermore, when phenylephrine was used to correct MAP, a 
decreased in rSO2 value was seen (109). One explanation might be that 
phenylephrine caused extra-cerebral vasoconstriction as demonstrated in previous 
studies (55-58). In our first study, we challenged the organ hierarchy by using 
individualised CI and demonstrated that rSO2 was reserved in all cardiac surgery 
patients. However, we did not monitor StO2, and therefore we do not know whether 
the preserved rSO2 was caused by recruitment of blood from the peripheral muscle 
tissue.   
 
5.2. STUDY II 
During low cardiac output states, a vascular response is initiated though a central 
mechanism that acts via baroreceptors and chemoreceptors to maintain blood 
volume, causing vasoconstriction in peripheral tissues and thereby markedly 
reducing muscular perfusion in haemodynamic shock (8). This vascular response 
implies that muscle is one of first tissues where perfusion is down-regulated during 
insufficient systemic circulation, and the last one where perfusion is re-established 
after adequate systemic circulation has been restored (8). Indeed we found that StO2 
was a fast-reacting parameter that decreased during low blood flow and reflected 
insufficient muscle tissue oxygenation in Group II (35 mL/kg/min) in accordance 
with the ischaemic metabolic changes detected by microdialysis in muscular tissue. 
Our finding is supported by a previous animal haemorrhage model (111) in which 
StO2 of the right hind limb was compared to systemic parameter during 
resuscitation. The main conclusions were that StO2 measured in the hind limb was 
reliable as an index of severity of shock and resuscitation as systemic parameters. 
Although the studies have different setups and causes of low blood flow, our CPB 
model also simulates severe shock at the lowest level of blood flow (35 ml/kg/min 
that equals a reduction >50 % of blood flow). However, we also observed a rapid 
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decrease in StO2 in Group I (47 mL/kg/min), but the decrease was insignificant and 
may be explained by the small number of animals in group I. In our study, there was 
a correlation between systemic metabolism (SvO2 and lactate) and StO2. On the 
contrary, we could not show a correlation between the regional measured 
metabolomics (LPR muscle, gut, or brain) and StO2 (a surrogate marker of global 
hypoperfusion) or the regional measured metabolomics (LPR muscle, gut, or brain) 
and lactate. However, several studies have shown that the correlation between 
systemic parameters and peripheral microcirculation is difficult to prove (112-114). 
Oxygen transport to the cells is determined by 1) convective flow, i.e. the transport 
of red blood cells to capillary compartment and 2) a passive diffusion, the oxygen 
diffusion from red blood cells to the mitochondria for ATP production. During 
resuscitation the convective flow is optimised, but it may not lead to an optimisation 
of the passive diffusion of oxygen (114-115). Indeed in our study, we were only able 
to demonstrate a correlation between systemic metabolism and the decreasing StO2 
(convective level), but not with the extracellular metabolic changes measured with 
microdialysis (diffusion level), which reflects intracellular concentrations of 
biomarkers that easily diffuse across cell membranes, such as lactate and pyruvate. 
Indeed, in our study, one of the challenges is in terms of defining tissue ischaemia 
using microdialysis, as systemic lactate levels are increased in our low flow animal 
model. Thresholds are known for LPR of brain (116) and muscle tissue (117), but no 
validated LPR threshold of colon ischaemia has been described. However, systemic 
lactate levels may influence luminal lactate concentration when serum lactate 
exceeds 5 mmol/l (118). Therefore, systemic lactate values in the present study may 
have affected measured tissue lactate. In study II, we challenged the organ hierarchy 
by construction of a low blood flow porcine model, where we demonstrated that 
StO2 was a fast-reacting parameter, but we were unable to demonstrate a correlation 
between StO2 and the muscle tissue metabolomics.  
 
 
 
5.3. STUDY III 
Muscle tissue has a low resting metabolic rate and has a high tolerance to ischaemia 
(6). The NIRS monitor primarily reflects the oxygen balance of regional tissue (52). 
As blood flow is reduced, muscle tissue DO2 falls; to counteract the decrease in 
DO2, an increased extraction is seen, but if the compensatory mechanisms are 
exceeded, the muscle tissue VO2 will fall and the DO2-VO2 relationship may become 
linear. Due to the low metabolic rate of muscle tissue, the VO2-DO2 relationship 
may initially be linear when muscle blood flow is severely reduced if haemoglobin 
concentration and oxygen content are stable. In study III, we found that during 
inadequate systemic circulation, StO2 remained high until muscle blood flow had 
decreased to about 50%, after which StO2 almost linearly followed the fall in muscle 
blood flow. Our result may explain the conflicting results regarding the ability of 
NIRS to detect blood loss and hypovolemia in the perioperative setting. In a 
previous study (119), a 500-ml blood loss during blood donation did not lead to 
changes in StO2 variables in awake volunteers. This is in contrast to a study using 
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lower body negative pressure technique to mimic central hypovolemia, where StO2 
did decrease in awake volunteers (92). From the perspective of our study, it seems 
that a rather dramatic systemic blood flow decrease is needed before StO2 decreases. 
Indeed, a compensatory mechanism like that shown in a recent study (120) where a 
haematocrit less than 0.22 resulted in an unchanged StO2 due to an increased 
regional blood flow may also be a part of the explanation. Another important issue 
when StO2 is used to detect hypovolemia is the application site and the sensors 
measuring depth. The underlying muscle groups have a variable sensitivity with 
regard to detecting central hypovolemia (92), and the sensors measuring depth are 
likewise important as they determine the influence from non-muscular tissue on the 
StO2 value (54, 90-91). In animal research, the measuring sites and depth of muscle 
tissue are poorly validated, although it has been proposed that the muscle of the hind 
limb in pigs reflects the severity of shock and resuscitation in a trauma porcine 
model (70). We estimated the muscle tissue perfusion in three different depths 1–2 
cm, 2–4 cm, and 4–6 cm in the musculus gracilis of the non-cannulated back leg and 
found that muscle tissue perfusion showed the same trends at the three depths. This 
is in accordance with a previous human study (92). In study III, we demonstrated 
that StO2 first decreased when muscle tissue perfusion was decreased by 50%. 
Consequently StO2 may not be the optimal marker of peripheral hypoperfusion. 
 
5.4. STUDY IV 
In major cardiac surgery neurologic complications remain high (121-122). Indeed, 
after CABG 1.6–5% of patients experience a stroke (121) and cognitive decline is 
even more common, although it decreases to 10–20% of the patients after 1 year 
(123). It is well described that the brain’s oxygen supply is maintained by a stable 
CBF governed by cerebral pressure-flow autoregulation as long as MAP is within 
the range of 50 to 150 mmHg (33, 123). Likewise it has been demonstrated that CBF 
is independent of MAP evaluated by a static methodology, the 133Xenon clearance 
technique during CPB (7, 123). However, a more recent study using transcranial 
Doppler demonstrated that CBF is CPP pressure dependent during CPB. In his 
study, the CPP varied between 30 and 70 mmHg, while the CBF velocity was 
measured with transcranial Doppler. A positive slope with increasing CPP was 
demonstrated that likely reflects similar slope changes in CBF (124). Our study II 
points in the same direction because the cerebral metabolism was decreased when 
CPB blood flow was reduced to >50%, indicating that CPB blood flow might be as 
important as MAP.  
Indeed in the experimental study IV, we found that CPB blood flow was a main 
determinant of CBF measured by PET-CT during low blood flow. Furthermore, high 
MAP did not protect against cerebral hypoperfusion. This corresponds with the 
findings of Soma et al., concluding that MAP does not govern CBF during 
hypothermic CPB and a blood flow above 40 mL/kg/min is enough to achieve an 
adequate cerebral perfusion (125). However, Soma et al. (125) used hypothermia, 
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which reduces the metabolic rate, causing decreased VO2 demands, and thereby 
allowing a lower CPB blood flow to adequately meet cerebral perfusion demands 
(126). Indeed, conflicting results exists with regard to what constitutes sufficient 
CBF to meet cerebral metabolism when normothermic CPB blood flow is used in 
experimental models. During normothermia CPB, CBF is preserved using blood 
flows of 80–100 mL/kg/min (6, 127–129). However, reducing normothermic CPB 
blood flow to 70–50 mL/kg/min for 2 hours led to increasing cerebral metabolic 
derangement (130). Using nearly the same CPB blood flow (47.5 mL/kg/min) for 1-
hour, cerebral metabolism was preserved in our study II. Similarly, O’Dwyer et al. 
using radioactive microspheres also showed that CBF is preserved at a 
normothermic CPB blood flow of 50 mL/kg/min (127). Furthermore Boston et al. 
showed preserved cerebral blood flow over wider range of CPB blood flows of 1.7–
2.3 mL/min/m2, corresponding to 33–45 mL/kg/min (6).  
The use of different 1) animal models, 2) CPB blood flows, and the different 3) 
cerebral monitoring devices makes comparison very difficult. Indeed, in our study 
IV we found that going from pulsatile to non-pulsatile blood flow of 60 mL/kg/min 
led to an increased CBF. This is in contrast to a lamb study where initiating a CPB 
blood flow of 150 mL/kg did not increase CBF (131). Animals have lower brain size 
in relation to body weight (132) compared to humans and therefore the normal 
relative flow to the brain is higher in humans than in all other species. Thus, a CPB 
blood flow of 60 mL/kg/min in our pigs might produce a luxury perfusion of the 
brain. However we did not collect rSO2 values due to the thickness of the pig’s skull, 
so luxury brain oxygenation cannot be confirmed. 
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CHAPTER 6. ADVANTAGES AND 
LIMITATIONS 
 
6.1. STUDY DESIGN  
In study I, the crossover design was strong, as patients were their own control. 
However, the study included only cardiac surgery patients with a normal ejection 
fraction, and individual CI may not be sufficient in cardiac surgery patients with a 
low ejection fraction because their ability to compensate this is reduced. 
In studies II–IV, we chose to randomise CPB to two lower blood flows, and return 
to the initial blood flow of 60 mL/kg/min, thereby permitting the pig to be its own 
control. One concern is that the initial blood flow of 60 mL/kg/min could be viewed 
to be in the lower end for pigs weighing 80 kg. However, the literature is very sparse 
concerning optimal or normal CPB blood flow rates for pigs, but most studies 
consider a CPB blood flow of 70–100 mL/kg/min to be optimal in porcine models 
(133), and therefore we chose a blood flow of 60 mL/kg/min to prevent 
hyperperfusion in our porcine model. Processing the results of the study II, the 
initial blood flow of 60 mL/kg/min resulted in SvO2 values of 50–60%, but it should 
be pointed out that 60 mL/kg/min is in the lower end of a normal optimal blood 
flow. In our studies III and IV using the same blood flow of 60 mL/kg/min, we 
found median values of SvO2 to be 57% and median lactate values to be 1.1 
mmol/L. 
Indeed, the study design itself can be discussed. Our aim was to construct a porcine 
model to test whether StO2 was able to identify low blood flow during CPB. 
Another study design than the one we used could have been considered. A stepwise 
decrease in CPB blood flow would lead to a spill over from the previous blood flow 
steps. An alternatively design CPB blood flow could be to decrease to a lower blood 
flow, then return to the starting CPB blood flow before a new lower CPB blood flow 
was chosen. However, this study design is time consuming, and if perfusion time is 
prolonged, the CPB itself will affect both the systemic and regional parameters.  
 
6.2. CHOICE OF ANIMAL MODEL 
Many different animal models have been used for haemodynamic evaluation over 
the past years. Rodents have yielded some of the information, but many differences 
exist between the cardiovascular systems of rodents and humans such as heart rate, 
oxygen consumption, and adrenergic receptor ratios (134). Pigs have gained favour 
over dogs, in part because of marked differences in the coronary anatomy of dogs 
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and humans (134). The porcine heart closely resembles the human heart in terms of 
its coronary circulation and haemodynamics. The physiological functions are 
comparable in size with humans, allowing the testing of devices that can also be 
used in humans. For these reasons, the Danish Landrace pig was chosen as 
experimental model. However, in order to be able to compare animal studies, it is 
important that the animals are weight- and age-matched (134).  
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CHAPTER 7.  MAIN CONCLUSIONS  
 
The four studies forming this thesis contributed with novel findings regarding the 
interpretation of metabolism in cerebral and muscle tissue during individually 
defined blood flow (study I – human study) and low flow states (studies II–IV – 
animal studies). Study I indicates that the blood flow during normothermic CPB 
may be safe at a wider range than 2.2–2.5 L/min/m2. Thus, although the individual 
blood flow did not improve cerebral or systemic perfusion during CPB, the present 
study showed that during elective heart surgery an individual CPB flow of 1.9 
L/min/m2 to 3.1 L/min/m2 had a similar cerebral and global oxygenation as did a 
CPB flow calculated on the basis of the individual BSA. Furthermore, in study IV 
we found that CPB blood flow is important for maintaining CBF and that increased 
MAP does not protect against cerebral hypoperfusion in an experimental porcine 
model using PET-CT for evaluation of adequate CBF.  
During inadequate systemic circulation, StO2 reacted rapidly and indicated that 
global tissue perfusion was insufficient even when systemic circulation was restored 
after a period of systemic hypoperfusion (study II). However, we also demonstrated 
that during severe, inadequate systemic circulation, StO2 remained high until muscle 
blood flow had decreased to about 50%, after which StO2 almost linearly followed 
the fall in muscle blood flow (study III). The finding that muscle blood flow 
decreases markedly before StO2 decreases suggests that StO2 cannot be used as a 
single measurement method for evaluation of regional or systemic circulation. 
Further studies are needed to investigate the precise mechanism behind the high 
StO2 value even when muscle tissue perfusion is severely reduced. 
 
 
7.1. FUTURE PERSPECTIVES 
The anaesthesiologist’s every day clinical scenario is the evaluation of adequate 
tissue oxygenation in patients undergoing acute and elective surgery or admitted to 
the emergency and intensive departments. However, the well-established systemic 
parameters are global assessments, but are insufficient and do not ensure adequate 
regional tissue perfusion. Optimising diagnosis of insufficient tissue perfusion 
during low blood flow conditions, there is an increasing interest in non-invasive 
measurement of tissue microcirculatory changes, such as NIRS. In cardiac surgery, 
neurological complications are still common, and hypoperfusion appears to be 
central to their pathogenesis. As NIRS is non-invasive and easy to use, it is already 
used in cardiac surgery. However, the clinical benefit obtained from NIRS 
monitoring has so far failed to definitively demonstrate that interventions to correct 
cerebral desaturations improve neurological outcomes, and therefore rSO2 is not 
used routinely in cardiac surgery. New research is looking into other patient groups. 
Studies in septic patients using rSO2 combined with systemic parameters (central 
CEREBRAL AND MUSCLE BLOOD METABOLISM AT LOW BLOOD FLOWS DURING CARDIOPULMONARY 
42 
 
 
venous oxygen saturation and lactate) have revealed a new approach to identify 
septic patients with a high risk of mortality (135). Another interesting finding was 
recently made in a physiological study in which apnoea divers were used to 
stimulate apnoea with the aim of mimicking the missing ventilation during clinical 
scenarios such as difficult intubation “cannot ventilate cannot intubate”, 
laryngospasm, or cardiopulmonary resuscitation. During a maximal breath hold 
manoeuvre, the study showed that rSO2 and SaO2 were correlated and both 
decreased significantly, but more importantly that the rSO2 returned faster to 
baseline after apnoea, suggesting that it could be useful during pulseless 
resuscitation or difficult airway management (136).  
Studies have shown that the distal extremities exhibit an early vasoconstrictor 
response in models of hypovolemia (91–92). Therefore, monitoring of muscle tissue 
oxygenation may be beneficial for detecting early signs of hypovolemia in patients. 
In our studies, rapid response in StO2 was seen but only during severe CPB blood 
flow reductions, and under these conditions, a sustained lower level of StO2 after re-
established blood flow was also seen, indicating a telltale function of StO2. New 
research is being done using sublingual microcirculatory perfusion with side-stream 
dark field imaging that visualises the movement of single red blood cells, and the 
latest research shows that this technique could be used to evaluate fluid responseness 
(137).  
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